Anti-inflammatory neuropeptides: A new class of endogenous immunoregulatory agents

This publication has 52 references indexed in Scilit:

• Reduction in hypophyseal growth hormone and prolactin expression due to deficiency in ghrelin receptor signaling is associated with Pit-1 suppression: Relevance to the immune system
  Brain, Behavior, and Immunity, 2008
• Stimulatory and suppressive signal transduction regulates vasoactive intestinal peptide receptor-1 (VPAC-1) in primary mouse CD4 T cells
  Brain, Behavior, and Immunity, 2008
• TCR signaling and environment affect vasoactive intestinal peptide receptor-1 (VPAC-1) expression in primary mouse CD4 T cells
  Brain, Behavior, and Immunity, 2008
• Neuropeptides Rescue Mice from Lethal Sepsis by Down-regulating Secretion of the Late-Acting Inflammatory Mediator High Mobility Group Box 1
  The American Journal of Pathology, 2008
• The diminishment of experimental autoimmune encephalomyelitis (EAE) by neuropeptide alpha-melanocyte stimulating hormone (α-MSH) therapy
  Brain, Behavior, and Immunity, 2008
• Therapeutic effect of cortistatin on experimental arthritis by downregulating inflammatory and Th1 responses
  Annals of the Rheumatic Diseases, 2007
• Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens
  Nature Reviews Immunology, 2006
• Antiarthritic effect of VIP in relation to the host resistance against Candida albicans infection
  International Immunology, 2004
• Points of control in inflammation
  Nature, 2002
• Vasoactive intestinal peptide and pituitary adenylate cyclase‐activating polypeptide promote in vivo generation of memory Th2 cells
  The FASEB Journal, 2002